KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Invested Capital: 2009-2025

Historic Invested Capital for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $7.8 billion.

  • Quest Diagnostics' Invested Capital fell 40.43% to $7.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 billion, marking a year-over-year decrease of 40.43%. This contributed to the annual value of $13.0 billion for FY2024, which is 17.87% up from last year.
  • According to the latest figures from Q3 2025, Quest Diagnostics' Invested Capital is $7.8 billion, which was up 0.39% from $7.8 billion recorded in Q2 2025.
  • Quest Diagnostics' Invested Capital's 5-year high stood at $13.1 billion during Q3 2024, with a 5-year trough of $5.9 billion in Q2 2021.
  • Over the past 3 years, Quest Diagnostics' median Invested Capital value was $7.4 billion (recorded in 2024), while the average stood at $8.6 billion.
  • Its Invested Capital has fluctuated over the past 5 years, first plummeted by 43.17% in 2021, then surged by 93.47% in 2024.
  • Quest Diagnostics' Invested Capital (Quarterly) stood at $10.5 billion in 2021, then dropped by 5.57% to $9.9 billion in 2022, then climbed by 11.55% to $11.1 billion in 2023, then climbed by 17.87% to $13.0 billion in 2024, then plummeted by 40.43% to $7.8 billion in 2025.
  • Its Invested Capital stands at $7.8 billion for Q3 2025, versus $7.8 billion for Q2 2025 and $7.2 billion for Q1 2025.